Sergey Aksenov

Sergey Aksenov

Company: Novartis Institutes for BioMedical Research (NIBR)

Job title: Senior, Preclinical & Early Development Pharmacometrics

Seminars:

Panel Discussion: Dose Optimization for Neurological Gene Therapies 12:30 pm

Read more

day: Day One: Track B AM

Considerations for Translational Dose Selection for Gene Therapies 11:15 am

Reviewing pharmacological concepts for gene therapy and outline a preclinical dose selection research program for gene therapy programs (i.e what needs to be measured in what species NHP vs other species, what are objectives of NHP biodistribution studies) Describing a mathematical model approach to analyzing data from biodistribution studies, with the goal of informing first-in-human…Read more

day: Day One: Track B AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.